Volume 30, Number 11—November 2024
Research Letter
Epidemiology of Streptococcus pyogenes Disease before, during, and after COVID-19 Pandemic, Germany, 2005–2023
Figure

Figure. Number of cases in study of epidemiology of Streptococcus pyogenes disease before, during, and after COVID-19 pandemic, Germany, 2005–2023. A) Noninvasive cases; B) invasive cases. Values indicate-patients per year; regression line and slope are shown. Dark gray indicates data used for calculation of linear regression (prepandemic); light gray indicates pandemic and postpandemic data, including regression line extrapolated from prepandemic data. β values indicate increases.
Page created: August 02, 2024
Page updated: October 23, 2024
Page reviewed: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.